QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Notes Payable and Debentures (Details Narrative)

Notes Payable and Debentures (Details Narrative) - USD ($)			1 Months Ended			3 Months Ended		6 Months Ended
	Dec. 12, 2017	Mar. 22, 2017	Jun. 30, 2018	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2018	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017	Sep. 30, 2016
Due date of debt instrument		Dec. 31, 2017
Exercise price of warrants			$ 0.50			$ 0.50		$ 0.50
Discount original issue of discount			$ 0			$ 0		$ 0		$ 1,062
Secured convertible debentures principal amount			165,000			165,000		165,000		165,000
Common stock price per share		$ 0.15
Payment for defaults		$ 30,000
Late penalty		15,000
Accrued interest		$ 15,000
Debt conversion shares issued, value
Bridge note embedded conversion feature			3,300,000			3,300,000		3,300,000		3,270,000
Convertible bridge notes, net			3,300,000			3,300,000		3,300,000		3,270,000
Income and (charge) to earnings						104,051		345,324
Bridge Offering [Member]
Bridge note embedded conversion feature										600,000
Bridge offering amount										23,756
Bridge Offering [Member] \| Three Directors and One Shareholder [Member]
Debt conversion shares issued, value							$ 168,152
Bridge Offering [Member] \| Tranche [Member]
Convertible promissory note					$ 1,050,000		$ 1,050,000
Convertible Promissory Notes [Member]
Debt face amount			2,081,908			2,081,908		$ 2,081,908
Original issuance discount percentage								50.00%
Conversion valuation closing amount								$ 5,000,000
Conversion valuation ceiling amount								12,000,000
Conversion valuation floor amount								6,000,000
Convertible bridge notes, net			$ 3,300,000			$ 3,300,000		$ 3,300,000
Short-term debt, term								36 months
Annual interest rate			15.00%			15.00%		15.00%
Follow-On Bridge Offering [Member]
Short-term debt, term								36 months
Follow-On Bridge Offering [Member] \| July 2018 [Member]
Debt face amount			$ 250,000			$ 250,000		$ 250,000
Follow-On Bridge Offering [Member] \| Three Accredited Investors [Member]
Debt face amount			290,000			290,000		290,000
Five Follow-On Bridge Offering [Member]
Accrued interest			7,664			7,664		7,664
Debt conversion shares issued, value			50,000
Bridge note embedded conversion feature			$ 540,000			540,000		540,000
Debt instrument, description			These new notes mature in two years from issuance instead of three years.
Debt conversion into shares			613,451
Five Follow-On Bridge Offering [Member] \| July 2018 [Member]
Bridge note embedded conversion feature			$ 540,000			540,000		540,000
Modification and Extension Agreement [Member] \| Senior Secured Convertible Debentures [Member]
Due date of debt instrument				Jul. 31, 2018	Jul. 31, 2017
Discount original issue of discount			20,750			20,750		20,750
Secured convertible debentures principal amount			$ 165,000			$ 165,000		$ 165,000		$ 165,000
Common stock price per share				$ 0.10
Modification and Extension Agreement [Member] \| Senior Secured Convertible Debentures [Member] \| Maximum [Member]
Debt conversion price per share					$ 0.21		$ 0.21
Modification and Extension Agreement [Member] \| Senior Secured Convertible Debentures [Member] \| Minimum [Member]
Debt conversion price per share					$ 0.15		$ 0.15
Verbal Agreement [Member]
Exercise price of warrants											$ 0.50
Loan Agreement [Member] \| One Accredited Investor [Member]
Debt face amount	$ 150,000
Short-term debt, interest rate	20.00%
Shares issued for loan issuance costs	100,000
Value of shares issued for loan issuance costs	$ 26,000
Loan issuance cost paid in cash	$ 3,000